|
THE SIMPLE FACTSTM...Medtronic Infuse Bone Graft is a man-made liquid bone graft that uses recombinant human Bone Morphogenetici Protein (rhBMP-2), and is used to encourage bone growth and replace damaged spinal disks. The FDA approved the infuse bone graft in 2002.
On July 1, 2008, the FDA alerted physicians of reports of life-threatening complications, problems or injury associated with recombinant human Bone Morphogenetic Protein (rhBMP) when used in the cervical spine and that the Medtronic Infuse Bone Graft had not been approved for use in this area and was considered an off label use of the product.
POTENTIAL PROBLEMS: MEDTRONIC INFUSE BONE GRAFT
When the Infuse Bone Graft is used in neck cervical spine surgery, it may be associated - when used off label - with a number of serious complications, injury or problems which usually occur within 2 to 14 days following neck/cervical surgery. Some of the complications or problems may be:
- Compression of the Airway
If you are suffering a side effect/injury from use of the infuse bone graft - off label - in neck cervical spine surgery, please seek and consult with your healthcare provider as soon as possible.
For more information on Medtronic Infuse bone Graft and the FDA review/reports, click here.
Quite frankly, the simple factsTM about the Medtonic Infuse Bone Graft product and the possible complications and/or injuries that may be caused by using the Medtronic Infuse Bone Graft are unacceptable.
We are investigating claims of off label use of Medtronic Infuse Bone grafts in connection with possible complications, injury, side effects, problems or injuries from the use of the Infuse bone graft.
We are here to help you protect your legal rights and the legal rights of your loved ones. |
